. | Total study population n = 219 . | Low-voltage areas . | P-value . | |
---|---|---|---|---|
No (n = 164) . | Yes (n = 55) . | |||
Age (years) | 65 (57–72) | 62 (55–70) | 69 (64–75) | <0.001 |
Females | 89 (41) | 57 (35) | 32 (58) | 0.002 |
Persistent AF | 130 (59) | 84 (51) | 46 (84) | <0.001 |
Low-voltage areas | 55 (25) | — | 100% | |
BMI (kg/m2) | 30 (26–33) | 29 (26–33) | 30 (26–33) | 0.277 |
eGFR (mL/min/1.73 m2) | 78 (64–89) | 80 (68–93) | 69 (60–83) | 0.001 |
LAV (mL/BSA) (CMR) | 39 (30–50) | 37 (28–45) | 49 (36–56) | <0.001 |
LA-EF (biplane) (%) (CMR) | 31 (21–55) | 39 (23–60) | 19 (15–28) | <0.001 |
LA diameter (mm) (echo) | 44 (39–48) | 43 (38–48) | 45 (42–49) | 0.042 |
LV-EF (biplane) (%) (echo) | 56 (47–61) | 56 (47–61) | 55 (47–59) | 0.374 |
APPLE | 2 (1–3) | 2 (1–3) | 3 (2–4) | <0.001 |
(m)APPLEa | 2 (1–3) | 2 (1–3) | 3 (3–4) | <0.001 |
. | Total study population n = 219 . | Low-voltage areas . | P-value . | |
---|---|---|---|---|
No (n = 164) . | Yes (n = 55) . | |||
Age (years) | 65 (57–72) | 62 (55–70) | 69 (64–75) | <0.001 |
Females | 89 (41) | 57 (35) | 32 (58) | 0.002 |
Persistent AF | 130 (59) | 84 (51) | 46 (84) | <0.001 |
Low-voltage areas | 55 (25) | — | 100% | |
BMI (kg/m2) | 30 (26–33) | 29 (26–33) | 30 (26–33) | 0.277 |
eGFR (mL/min/1.73 m2) | 78 (64–89) | 80 (68–93) | 69 (60–83) | 0.001 |
LAV (mL/BSA) (CMR) | 39 (30–50) | 37 (28–45) | 49 (36–56) | <0.001 |
LA-EF (biplane) (%) (CMR) | 31 (21–55) | 39 (23–60) | 19 (15–28) | <0.001 |
LA diameter (mm) (echo) | 44 (39–48) | 43 (38–48) | 45 (42–49) | 0.042 |
LV-EF (biplane) (%) (echo) | 56 (47–61) | 56 (47–61) | 55 (47–59) | 0.374 |
APPLE | 2 (1–3) | 2 (1–3) | 3 (2–4) | <0.001 |
(m)APPLEa | 2 (1–3) | 2 (1–3) | 3 (3–4) | <0.001 |
Data are presented as median (IQR) or n (%).
AF, atrial fibrillation; BMI, body mass index; BSA, body surface area; CMR, cardiovascular magnetic resonance imaging; eGFR, estimated glomerular filtration rate; EF, emptying fraction; IQR, interquartile range; LAV, left atrial volume; LA, left atrial; LV, left ventricular.
Available in 189 patients.
. | Total study population n = 219 . | Low-voltage areas . | P-value . | |
---|---|---|---|---|
No (n = 164) . | Yes (n = 55) . | |||
Age (years) | 65 (57–72) | 62 (55–70) | 69 (64–75) | <0.001 |
Females | 89 (41) | 57 (35) | 32 (58) | 0.002 |
Persistent AF | 130 (59) | 84 (51) | 46 (84) | <0.001 |
Low-voltage areas | 55 (25) | — | 100% | |
BMI (kg/m2) | 30 (26–33) | 29 (26–33) | 30 (26–33) | 0.277 |
eGFR (mL/min/1.73 m2) | 78 (64–89) | 80 (68–93) | 69 (60–83) | 0.001 |
LAV (mL/BSA) (CMR) | 39 (30–50) | 37 (28–45) | 49 (36–56) | <0.001 |
LA-EF (biplane) (%) (CMR) | 31 (21–55) | 39 (23–60) | 19 (15–28) | <0.001 |
LA diameter (mm) (echo) | 44 (39–48) | 43 (38–48) | 45 (42–49) | 0.042 |
LV-EF (biplane) (%) (echo) | 56 (47–61) | 56 (47–61) | 55 (47–59) | 0.374 |
APPLE | 2 (1–3) | 2 (1–3) | 3 (2–4) | <0.001 |
(m)APPLEa | 2 (1–3) | 2 (1–3) | 3 (3–4) | <0.001 |
. | Total study population n = 219 . | Low-voltage areas . | P-value . | |
---|---|---|---|---|
No (n = 164) . | Yes (n = 55) . | |||
Age (years) | 65 (57–72) | 62 (55–70) | 69 (64–75) | <0.001 |
Females | 89 (41) | 57 (35) | 32 (58) | 0.002 |
Persistent AF | 130 (59) | 84 (51) | 46 (84) | <0.001 |
Low-voltage areas | 55 (25) | — | 100% | |
BMI (kg/m2) | 30 (26–33) | 29 (26–33) | 30 (26–33) | 0.277 |
eGFR (mL/min/1.73 m2) | 78 (64–89) | 80 (68–93) | 69 (60–83) | 0.001 |
LAV (mL/BSA) (CMR) | 39 (30–50) | 37 (28–45) | 49 (36–56) | <0.001 |
LA-EF (biplane) (%) (CMR) | 31 (21–55) | 39 (23–60) | 19 (15–28) | <0.001 |
LA diameter (mm) (echo) | 44 (39–48) | 43 (38–48) | 45 (42–49) | 0.042 |
LV-EF (biplane) (%) (echo) | 56 (47–61) | 56 (47–61) | 55 (47–59) | 0.374 |
APPLE | 2 (1–3) | 2 (1–3) | 3 (2–4) | <0.001 |
(m)APPLEa | 2 (1–3) | 2 (1–3) | 3 (3–4) | <0.001 |
Data are presented as median (IQR) or n (%).
AF, atrial fibrillation; BMI, body mass index; BSA, body surface area; CMR, cardiovascular magnetic resonance imaging; eGFR, estimated glomerular filtration rate; EF, emptying fraction; IQR, interquartile range; LAV, left atrial volume; LA, left atrial; LV, left ventricular.
Available in 189 patients.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.